Company overview
InSphero offers scalable 3D in vitro models for non-animal drug testing in pharma and life sciences, including ARCTis™ cryopreserved human-derived 3D tumor models and 3D InSight™ Human Liver Microtissues. These solutions support liver disease research (MASH/NAFLD), toxicology, oncology, immunology, and safety assessment with high physiological relevance, reproducibility, and automation compatibility. They enable reliable prediction of human responses, reducing late-stage failures and accelerating drug discovery.
Insphero is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include 3d in vitro models, non-animal drug testing, liver toxicology, oncology tumor models, mash nash research.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://insphero.com/
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- 3d in vitro models, non-animal drug testing, liver toxicology, oncology tumor models, mash nash research
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What 3D in vitro models does InSphero offer for pharma R&D?
- InSphero provides ARCTis™ cryopreserved 3D tumor models, 3D InSight™ Human Liver Microtissues for liver disease and toxicology, and models for oncology, immunology, diabetes, and MASH/NAFLD, all with high scalability and physiological relevance.
- What are the key capabilities and applications of InSphero's platforms?
- Platforms offer high reproducibility, short turnaround times, multiplexing for imaging and readouts, compatibility with small molecules, biologics, and siRNAs, and applications in toxicology, safety testing, efficacy assessment, and tumor microenvironment studies.
- Does InSphero comply with regulatory standards for drug testing?
- InSphero's solutions include ISO quality-controlled 3D human tissue models used by major pharmaceutical companies worldwide for preclinical drug safety and efficacy testing.
- What geographies does InSphero serve and are they scalable?
- InSphero serves global pharmaceutical and biotech clients with automation-compatible, scalable 3D technology like Akura™ Microplates, enabling industrial-grade assays.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
